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Abstract
Background: Envenoming by viper snakes constitutes an important public health problem in Brazil and other developing
countries. Local hemorrhage is an important symptom of these accidents and is correlated with the action of snake venom
metalloproteinases (SVMPs). The degradation of vascular basement membrane has been proposed as a key event for the
capillary vessel disruption. However, SVMPs that present similar catalytic activity towards extracellular matrix proteins differ
in their hemorrhagic activity, suggesting that other mechanisms might be contributing to the accumulation of SVMPs at the
snakebite area allowing capillary disruption.
Methodology/Principal Findings: In this work, we compared the tissue distribution and degradation of extracellular matrix
proteins induced by jararhagin (highly hemorrhagic SVMP) and BnP1 (weakly hemorrhagic SVMP) using the mouse skin as
experimental model. Jararhagin induced strong hemorrhage accompanied by hydrolysis of collagen fibers in the
hypodermis and a marked degradation of type IV collagen at the vascular basement membrane. In contrast, BnP1 induced
only a mild hemorrhage and did not disrupt collagen fibers or type IV collagen. Injection of Alexa488-labeled jararhagin
revealed fluorescent staining around capillary vessels and co-localization with basement membrane type IV collagen. The
same distribution pattern was detected with jararhagin-C (disintegrin-like/cysteine-rich domains of jararhagin). In
opposition, BnP1 did not accumulate in the tissues.
Conclusions/Significance: These results show a particular tissue distribution of hemorrhagic toxins accumulating at the
basement membrane. This probably occurs through binding to collagens, which are drastically hydrolyzed at the sites of
hemorrhagic lesions. Toxin accumulation near blood vessels explains enhanced catalysis of basement membrane
components, resulting in the strong hemorrhagic activity of SVMPs. This is a novel mechanism that underlies the difference
between hemorrhagic and non-hemorrhagic SVMPs, improving the understanding of snakebite pathology.
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Introduction
Snakebite envenoming is an important neglected disease in
many tropical and subtropical developing countries. As recently
reviewed, globally, venomous snakebite is estimated to affect more
than 421,000 humans per year, with 20,000 of fatalities. However,
if we take into account the non-reported accidents, these data may
be as high as 1,841,000 envenomings and 94,000 deaths [1].
Antivenom therapy was set at the end of 19
th century and is still
the only efficient approach to treat snakebites. It cures systemic
symptoms of envenoming while the local effects are not covered
and usually leads to temporary or permanent disability observed in
many patients [2,3]. In Brazil, the majority of the accidents
reported to the Ministry of Health are caused by viper snakes [4].
The victims of viper envenoming frequently present systemic
disturbances in hemostasis including spontaneous bleeding and
blood incoagulability, and strong local effects characterized by
edema, ecchymoses, blisters and extensive hemorrhage [2].
Hemorrhagic toxins play an important role in vascular damage
and subsequent generation of ischemic areas that largely
contribute to the onset of local tissue necrosis that may result in
amputation of affected limbs [5,6].
The pathogenesis of venom-induced hemorrhage involves direct
damage of microvessels by the snake venom metalloproteinases
(SVMPs). They are multidomain Zn
2+-dependent proteinases that
share structural and functional motifs with other metalloprotei-
nases, such as MMPs (Matrix Metalloproteinases) and ADAMs (A
Disintegrin And Metalloproteinase) [7,8]. SVMPs are classified
from PI to PIII according to their domains constitution (Reviewed
by Fox and Serrano [9]). The mature form of the PI class is
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characteristic zinc-binding site present in all classes of SVMPs,
MMPs and some ADAMs. P-II and P-III SVMPs exhibit
additional non-catalytic domains, such as disintegrin, disintegrin-
like and cysteine-rich domains, similar to those found in ADAMs,
which are related to adhesive properties [9]. Despite sharing
similar catalytic activity, not all SVMPs induce hemorrhage in in
vivo models. In general, P-III SVMPs that include disintegrin-like
and cysteine-rich domains are potent hemorrhagic toxins while P-I
SVMPs show reduced hemorrhagic activity. There are also a
number of non-hemorrhagic SVMPs that may be found
preferentially in the P-I class and rarely in P-III class, which
often function as pro-coagulant enzymes [10,11,12].
The mechanism of hemorrhage induced by SVMPs has been
investigated in several studies [13,14,15,16,17]. However, the
precise molecular and cellular events associated with microvessel
disruption remain unknown. The degradation of vascular
basement membrane components has been proposed as a key
event for the onset of capillary vessel disruption. The four major
components of basement membranes are type IV collagen,
laminin, nidogen/entactin and perlecan. Type IV collagen and
laminin individually self-assemble into supramolecular structures,
and both networks are crucial for basement membrane stability
[18]. Nidogen/entactin and perlecan bridge the laminin and type
IV collagen networks, increasing their stability, influencing the
structural integrity of basement membranes [18,19]. Thus, the
hydrolysis of vascular basement membrane components by
SVMPs could profoundly affect the stability of the endothelium,
resulting in bleeding. In this regard, in vitro, SVMPs efficiently
degrade basement membrane components such as laminin, type
IV collagen, nidogen/entactin, presenting minor effects on
interstitial collagens [20]. However, catalytic activity is apparently
similar in hemorrhagic and non-hemorrhagic SVMPs, indicating
that the hydrolysis of basement membrane components is not the
only mechanism acting on vascular damage induced by the
hemorrhagic toxins.
Endothelial cells have also been investigated as potential targets
of hemorrhagic toxins. The survival signals promoted by
endothelial cell anchorage can be disrupted by SVMPs using
mechanisms dependent or independent of their proteolytic
activity. Both P-I and P-III SVMPs interfere with adhesion
components involved in focal adhesion between endothelial cells
and the extracellular matrix, affecting the organization of actin
filaments and stress fibers, which culminates in cell death by
apoptosis [21,22]. However, apoptosis of endothelial cells shows
little correlation with the hemorrhage induced by SVMPs.
Hemorrhagic and non-hemorrhagic SVMPs induce comparable
rates of apoptosis in endothelial cells in culture [23] and the onset
of hemorrhage induced by SVMPs occurs much earlier than the
induction of apoptosis of endothelial cells in vitro. In addition, no
apoptosis of endothelial cells was observed in SVMP-induced
hemorrhage in the dermis of mouse ear skin, in vivo [24].
An additional mechanism involved in SVMPs hemorrhagic
activity could be related to the accumulation of hemorrhagic SVMPs
close to capillary vessels, through the adhesive properties of the non-
catalytic domains, allowing the hydrolysis of basement membrane
components and disruption of the blood vessels. This mechanism has
been suggested previously [14,16,25], but up to the moment, there
are no experimental evidences that this occurs in vivo. In this study, we
evaluated this hypothesis analyzing the tissue distribution of
jararhagin, a highly hemorrhagic P-III SVMP, and BnP1, a weakly
hemorrhagic toxin from P-I class, and the hydrolysis of basement
membrane collagen and laminin within the hemorrhagic lesions,
using the mouse skin as experimental model. We clearly showed a
correlationbetweenthebindingoftoxinstobasementmembraneand
their ability to induce hemorrhage. Moreover, we showed the in situ
degradation of basement membrane collagen IV, but not laminin,
suggesting that collagen is an important target for the tissue
accumulation of hemorrhagic SVMPs.
Methods
Ethics statement
The conducts and procedures involving animal experiments
were approved by the Butantan Institute Committee for Ethics in
Animal Experiments (License number CEUAIB 191/2004).
Animals
BALB/c mice (18–22 g body weight) were used throughout the
study.
Toxins
As a model for class P-I SVMP with low hemorrhagic activity,
we used BnP1 (GI:172044591), a 25 kDa metalloproteinase,
isolated from Bothrops neuwiedi venom according to Baldo et al.,
[23], which contains only the catalytic domain. Jararhagin
(GI:62468) was used as a model of highly hemorrhagic P-III
SVMP, comprised of catalytic, disintegrin-like and cysteine-rich
domains. It was isolated from Bothrops jararaca venom, as previously
described [26]. Jararhagin-C was isolated from Bothrops jararaca
venom as described [27]. It is devoid of catalytic activity and does
not induce hemorrhage, as it contains only the non-catalytic
domains of jararhagin – disintegrin-like and cysteine-rich. BSA
(Bovine serum albumin) was used as control of non-toxic protein in
different set of experiments. Toxins were used in the native form
or labeled with Alexa Fluor 488H (Molecular Probes, USA),
following the instructions of the manufacturer.
Histological analysis and detection of extracellular matrix
components
Groups of three BALB/c mice were intradermically injected
with jararhagin (10 mg) and BnP1 (5 mgo r5 0mg), dissolved in
Author Summary
Snakebite accidents by vipers cause a massive disturbance
in hemostasis and tissue damage at the snakebite area.
The systemic effects are often prevented by antivenom
therapy. However, the local symptoms are not neutralized
by antivenoms and are related to the temporary or
permanent disability observed in many patients. Although
the mechanisms involved in coagulation or necrotic
disturbances induced by snake venoms are well known,
the disruption of capillary vessels by SVMPs leading to
hemorrhage and consequent local tissue damage is not
fully understood. In our study, we reveal the mechanisms
involved in hemorrhage induced by SVMPs by comparing
the action of high and low hemorrhagic toxins isolated
from Bothrops venoms, in mouse skin. We show remark-
able differences in the tissue distribution and hydrolysis of
collagen within the hemorrhagic lesions induced by high
and low hemorrhagic metalloproteinases. According to our
data, tissue accumulation of hemorrhagic toxins near
blood vessel walls allowing the hydrolysis of basement
membrane components, preferably collagen IV. These
observations unveil new mechanistic insights supporting
the local administration of metalloproteinases inhibitors as
an alternative to improve snakebite treatment besides
antivenom therapy.
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received only 20 mL of PBS. After 15 minutes, the animals were
sacrificed by CO2 inhalation and the dorsal skin corresponding to
the site of the injection was carefully dissected out and fixed in
methacarn solution (60% methanol, 30% chloroform, 10% glacial
acetic acid) for 3 hour at 4uC and thereafter dehydrated in ethanol
and embedded in Paraplast (Merck, Germany). Sections of 5 mm
were adhered to glass slides using 0.1% poly-L-Lysine (Sigma, UK)
and dried at room temperature. Sections were dewaxed in xylene
and hydrated in distilled water. Each of the succeeding steps was
followed by washing with PBS. Some sections were stained with
hematoxylin and eosin for histological analysis. The detection of
collagen fibers was performed by staining the sections using the
picrossirus method, according to a previously described protocol
[28].
The staining of basement membrane components was per-
formed by immunofluorescence assays. After dewaxing and
hydrating, the slides were submitted to antigen retrieval using
enzymatic treatment of the sections with 4 mg/mL solution of pig
pepsin (1,120 units/mg protein) (Sigma, UK) in acid buffer
(pH 2.2), for 10 minutes at room temperature, followed by
incubation with blocking solution (PBS/BSA 10% and goat serum
1:1) for 1 hour at room temperature. Afterwards, the sections were
incubated with goat anti-rabbit type IV collagen polyclonal
antibody (Chemicon, USA), at a 1:40 dilution, or goat anti-rabbit
laminin polyclonal antibody (Chemicon, USA), at a 1:40 dilution,
for 18 hours at 4uC. After washing with PBS, the sections were
incubated with Alexa fluor 488 goat anti-rabbit IgG (Molecular
Probes, USA), at a 1:1000 dilution, for 90 minutes at room
temperature. The nuclear staining was performed with DAPI (49,
69-diamino-2-phenylindole, Sigma, UK), at a 1:1000 dilution.
Negative control consisted of omitting the primary antibody step
from the protocol. The sections were examined with a Confocal
Microscope LSM 510 Meta (Zeiss, Germany).
Distribution of toxins in skin vasculature
The distribution of toxins in the skin vasculature was evaluated
after intradermically injection of 10 mg of Alexa Fluor 488-labeled
jararhagin (Alexa488-Jar), 5 mg of Alexa Fluor 488-labeled
jararhagin-C (Alexa488-Jar-C) or 50 mg of Alexa Fluor 488-
labeled BnP1 (Alexa488-BnP1) in BALB/c mice. The control
group received 20 mL of Alexa Fluor 488-labeled bovine serum
albumin (Alexa488-BSA). After 15 minutes, the animals were
sacrificed by CO2 inhalation and the piece of dorsal skin on the
site of injection was carefully dissected, frozen in OCT (Optimal
cutting temperature) and sectioned 5 mm thick in the cryostat
(Leica, CM1510). The sections were then fixed in 3.7%
formaldehyde for 10 minutes at room temperature. Nonspecific
staining was blocked by incubating the sections for 1 hour at room
temperature with PBS containing 1% triton X-100, 5% normal
goat serum, 1% BSA, 0.5% glycine and 0.5% fish skin gelatin.
Then, the sections were incubated with donkey anti-rat CD-31
polyclonal antibody (BD Bioscience, USA), at a 1:40 dilution, or
goat anti-rabbit type IV collagen polyclonal antibody (Chemicon,
USA), at a 1:40 dilution, for 18 hours at 4uC. The sections were
washed with PBS and incubated with TRITC-labeled (Tetra-
methyl Rhodamine Isothiocyanate) goat anti-rat IgG (Jackson
ImmunoResearch, USA), at a 1:500 dilution, or TRITC goat anti-
rabbit IgG (Jackson ImmunoResearch, USA), at a 1:100 dilution,
for 2 hours at room temperature. The distribution of toxins in the
tissues was analyzed searching in at least 10 different fields of each
section. Alternately, the distribution of jararhagin was analyzed 45
minutes after its injection under the same experimental condition.
The sections were examined with a Confocal Microscope LSM
510 Meta (Zeiss, Germany).
Results
Morphological alterations induced by SVMPs in mouse
skin
In order to investigate the mechanisms involved in the
hemorrhage induced by SVMPs, we initially compared the
pathological alterations induced by jararhagin, a highly hemor-
rhagic P-III SVMP and BnP1, a weakly hemorrhagic P-I SVMP,
using the mouse skin as experimental model. Tissues were
inspected 15 minutes after injection of toxins in order to evaluate
the first events involved in the hemorrhagic lesions. At this period,
we focused on the direct action of venom toxins, avoiding
interference of secondary effects of endogenous components
released by the local reaction.
After 15 minutes, macroscopic analysis of the skin injected with
doses adjusted at the same molar basis (10 mg jararhagin and 5 mg
BnP1), revealed that jararhagin induced intense hemorrhage,
whereas only a small hemorrhagic spot at the site of the injection
was observed in the samples injected with BnP1 or PBS, used as
injection control (Fig. 1A). Only high doses of BnP1 (50 mg) was
able to induce hemorrhage, but less intense than jararhagin
(Fig. 1A). Morphological analysis under light microscopy showed
drastic hemorrhage in the hypodermis and also in the skeletal
muscle adjacent to hypodermis in mice injected with jararhagin
(Fig. 1B). The equivalent dose of BnP1 induced an enlargement of
skin thickness probably due to its edema-forming activity but did
not induce hemorrhagic alterations. When a hemorrhagic doses of
BnP1 (50 mg) was injected, edema was persistent and only sparse
spots of hemorrhage were detected in the hypodermis (Fig. 1B).
We also evaluated the action of jararhagin and BnP1 on dermal-
epidermal junctions by staining with antibodies anti-laminin and
anti-b4 integrin and no alteration of these structures were observed
after injection of toxins (data not shown). These results confirm the
differences in hemorrhagic activity of jararhagin and BnP1 and
show that most of the hemorrhagic incidence occurs in the
hypodermis.
In vivo degradation of extracellular matrix components
induced by SVMPs
Next, we investigated the integrity of extracellular matrix
components, mainly collagens and laminin, after injection of
hemorrhagic doses of jararhagin (10 mg) or BnP1 (50 mg). After 15
minutes, the control skin injected with PBS, showed a dense
network of collagen fibers stained by picrossirus. The bundles of
collagen fibers were closely packed characterizing a dense
connective tissue (Fig. 2 A, B). In contrast, mice injected with
jararhagin showed a clear loosening of the bundles of collagen
fibers in the dermis (Fig. 2C). In the hypodermis, where the
hemorrhagic lesion occurs, only a few weakly stained fibers were
observed, indicating a massive degradation of fibrillar collagen
(Fig. 2D). BnP1 induced only a discrete disorganization of collagen
fibers throughout the dermis (Fig. 2E) and the hypodermis
(Fig. 2F).
The effect of toxins on the distribution of type IV collagen and
laminin at the basement membrane was then evaluated by
immunofluorescence. In the control skin, type IV collagen (Fig. 3A)
and laminin (Fig. 3B) were observed as linear and continuous lines
surrounding small blood vessels and in the basement membrane of
skeletal muscle cells. In contrast, jararhagin induced a remarkable
alteration in the immunostaining of type IV collagen in the
basement membrane of blood vessels of the hypodermis, where
Mechanisms of Vascular Damage by SVMPs
www.plosntds.org 3 June 2010 | Volume 4 | Issue 6 | e727Figure 1. Action of jararhagin and BnP1 in mouse skin. A- Macroscopic view of mouse skin 15 minutes after i.d injection of toxins. No
hemorrhage was observed in the control samples, whereas the samples injected with jararhagin showed an evident hemorrhagic lesion. BnP1 (5 mg)
did not induce bleeding and only a small hemorrhagic lesion was detected when 50 mg of this toxin were used. B- Histological analysis of paraffin-
embedded sections. Control samples injected only with PBS showed typical histological features of normal skin. The samples injected with jararhagin
showed intense hemorrhage especially in the hypodermis region, and was also detected in the skeletal muscle layer. Only an extensive edema was
observed in the skin after injection of BnP1 (5 mg). Some hemorrhagic spots were observed after injection of 50 mg of BnP1. Hematoxylin and eosin
staining.
doi:10.1371/journal.pntd.0000727.g001
Figure 2. Action of jararhagin and BnP1 on the fibrillar collagen matrices. Paraffin-embedded sections of mouse skin 15 minutes after i.d
injection of 10 mg jararhagin and 50 mg of BnP1. Control samples injected with PBS showing the usual distribution of collagen forming closely packed
bundles of fibers (A, B). Jararhagin injected samples showed a clear loosening of the bundles of collagen fibers in the dermis (C) and fragmented
collagen fibers in the hypodermis region (D). Samples injected with BnP1 showed a moderate disorganization of collagen fibers throughout the
dermis (E, F). Picrossirius method staining.
doi:10.1371/journal.pntd.0000727.g002
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www.plosntds.org 4 June 2010 | Volume 4 | Issue 6 | e727Figure 3. Action of jararhagin and BnP1 on basement membrane components. Paraffin-embedded sections of mouse skin 15 minutes after
i.d injection of 10 mg of jararhagin and 50 mg of BnP1. Control samples were injected with PBS. A- Immunofluorescence for type IV collagen. Control
samples showed a continue immunoflurescent line surrounding small venules and skeletal muscle cells (green). Jararhagin induced remarkable
degradation in the immunostaining of type IV collagen in the basement membrane of blood vessels and skeletal muscle. BnP1 induced only a
moderate disorganization of type IV collagen in the basement membrane. B- Immunofluorescence for laminin. Control samples showed the usual
Mechanisms of Vascular Damage by SVMPs
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addition, jararhagin also promoted a notable reduction of type IV
collagen immunostaining in skeletal muscle basement membrane
(Fig. 3A). After injection of 50 mg of BnP1, only a slight alteration
in the immunostaining of type IV collagen was observed. The
immunoreaction in the basement membrane of blood vessels and
skeletal muscle was more diffuse than the pattern observed in the
control, with the presence of some spots. However, the alterations
induced by BnP1 are not comparable to the extensive disruption
induced by jararhagin on type IV collagen, whose immunoreac-
tion was practically abolished in blood vessels and skeletal muscle
basement membrane (Fig. 3A). The effect of jararhagin on laminin
distribution was less intense than that observed on type IV
collagen. The presence of laminin was detected in tissues injected
with jararhagin, but its distribution on basement membrane was
not as homogeneous as observed in control tissues suggesting
punctual disruptions of basement membrane integrity, probably as
a result of collagen degradation. Similar effects were induced by
BnP1 (Fig. 3B).
Distribution of toxins in the skin vasculature
The next step was to analyze the distribution of SVMPs in the
skin tissue. After 15 minutes of injection, when the hemorrhagic
lesion has already been set, jararhagin was located close to small
blood vessels stained by anti-CD31, in the hypodermis region
(Fig. 4B). It is interesting to note that co-localization with CD-31
was not observed, suggesting the accumulation of the toxin near
the blood vessels. In contrast, after injection of BnP1 (Fig. 4C),
only a weak and diffuse fluorescence was observed, slightly higher
than in control tissues (Fig. 4A). Similar deposition of the toxins
was observed in the skeletal muscle adjacent to the hypodermis.
High fluorescence was observed after jararhagin injection (Fig. 4E)
in the basement membrane of skeletal muscle and capillaries
suggesting its accumulation in these areas. After BnP1 injection
(Fig. 4F), only a weak fluorescence was observed. No fluorescence
was detected in control tissues (Fig. 4D). Similar pattern of toxin
distribution was detected up to 45 minutes after jararhagin
injection in areas adjacent to the main focus of the injection. This
toxin was detected around hypodermis blood vessels (Fig. 5A), and
close to the capillaries in the skeletal muscle (Fig. 5B).
In order to verify the binding of hemorrhagic toxins to the
basement membrane, we carried out a double-staining protocol
using Alexa488-labeled SVMPs and type IV collagen antibody.
According to figure 6, jararhagin showed co-localization with type
IV collagen in the basement membrane of venules and capillaries,
15 minutes after injection. Contrarily, no co-localization with type
IV collagen was observed in mouse skin injected with BnP1, which
showed a similar staining pattern to control samples (Fig. 6). These
distribution of laminin in the basement membrane (green). Jararhagin and BnP1 induced slight alteration in the distribution of laminin in the
basement membrane of blood vessels and skeletal muscle cells. The nuclear staining was performed with DAPI (blue). The sections were examined
with a Confocal Microscope LSM 510 Meta (Zeiss).
doi:10.1371/journal.pntd.0000727.g003
Figure 4. Distribution of Alexa488-labeled SVMPs on the skin vasculature. The cryosections were obtained 15 minutes after i. d. injection of
10 mg of Alexa488-Jar and 50 mg Alexa488-BnP1 in mouse skin. Samples injected with Alexa488-BSA were used as a control. The blood vessels were
stained with anti-rat CD-31 polyclonal antibody (red). Alexa488-Jar accumulated in the venules walls in the hypodermis region (B-green) as well as on
the basement membrane of skeletal muscle cells and capillaries (E). Alexa488-BSA (A, D) and Alexa488-BnP1 (C, F) did not concentrate around these
structures. The sections were examined with a Confocal Microscope LSM 510 Meta (Zeiss).
doi:10.1371/journal.pntd.0000727.g004
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basement membrane components, explaining their accumulation
near blood vessels.
We next addressed the role of non-catalytic domains of SVMPs
in the distribution of jararhagin on tissues. For that, mice were
injected with Alexa488- labeled jararhagin-C, which consists of
jararhagin disintegrin-like and cystein-rich domains, and its
distribution was observed in mouse skin. The distribution of
jararhagin-C in skin was the same for jararhagin: jararhagin-C was
detected close to the CD-31 marker around blood vessels in the
hypodermis (Fig. 7A), and close to capillaries in the skeletal muscle
(Fig. 7B), and co-localized with basement membrane type IV
collagen in the hypodermis venules (Fig. 7C). These results
strongly suggest that the non-catalytic domains are determinant to
hemorrhagic activity of SVMPs from P-III class, locating the
catalytic site specifically to the microvascular wall.
Discussion
In this work, we unveil an important step for understanding the
mechanisms involved in the expressive hemorrhage induced by
SVMPs, by comparing the in vivo degradation of extracellular
matrix proteins and the tissue distribution of jararhagin, a highly
hemorrhagic P-III SVMP, and BnP1, a weakly hemorrhagic P-I
SVMP, using the mouse skin as experimental model. This
comparison revealed that tissue localization and in vivo degradation
of collagens are key events in SVMPs induced hemorrhage.
Jararhagin induced a massive degradation of fibrillar collagen in
the hypodermis, where the hemorrhagic lesion was concentrated.
In the vascular basement membrane, type IV collagen was the
major substrate for jararhagin. In contrast, BnP1 was not able to
efficiently degrade these substrates or to induce hemorrhage.
Instead, a remarkable edema and dermal alteration were
observed, consistent with the dermonecrotic activity already
described for BaP1, a SVMP class P-I isolated from B. asper
venom [29,30]. Considering that the macromolecular organiza-
tion and the biomechanical stability of basement membrane are
mainly determined by the type IV collagen network [31], its
cleavage would alter the structural stabilization of the other related
basement membrane components. Consistent with that, we
observed that jararhagin induced only slight alterations in laminin
distribution, suggesting that its epitopes are conserved after
treatment with the toxin. This characteristic is not restricted to
snake venom pathology. Selective degradation of type IV collagen
has been associated with other pathologies involving toxic
metalloproteinases. The metalloproteinase from Vibrio vulnificus
(VVP) is a major determinant for skin lesions of this microorgan-
ism, which also causes hypodermic hemorrhage [32].
According to the literature, both P-I and P-III SVMPs are
similarly able to hydrolyze extracellular matrix components in vitro,
such as matrigel [33] and isolated components, such as type IV
collagen, laminin and fibronectin [20,33–37]. Escalante et al. [17]
showed that jararhagin and BaP1 had a similar proteolytic activity
on matrigel with a slightly different cleavage pattern, since BaP1,
exerted a limited proteolysis of both laminin and nidogen, whereas
jararhagin predominantly degraded nidogen. However, the
hydrolysis of extracellular matrix components in vitro occurs only
after long incubation periods, suggesting that distinct mechanisms
are involved in the basement membrane digestion in vivo. These
authors also analyzed the immunostaining of laminin, nidogen,
type IV collagen and the endothelial cell marker VEGFR-2
(vascular endothelial cell growth factor receptor 2) in mouse
gastrocnemius muscle injected with hemorrhagic doses of
jararhagin and BaP1, observing reduction in the number of
capillary vessels and a similar pattern of immunostaining for the
basement membrane components laminin, nidogen and type IV
collagen in muscular fibers after injection of BaP1 or jararhagin,
showing a disorganization of extracellular matrix [17]. Although
they showed the first evidence of the catalytic action of SVMPs in
vivo and morphological alterations in muscular tissues, the authors
failed to detect any difference between weakly and highly
hemorrhagic SVMPs.
A parameter not yet explored in the literature consisted of
eventual differences in the distribution of toxins in the damaged
tissues. In this study, jararhagin, but not BnP1, concentrated in the
vicinity of small venules and in capillaries of skeletal muscle. This
Figure 5. Distribution of Alexa488-Jar on the skin vasculature.
Cryosections were obtained 45 minutes after injection of 10 mgo f
Alexa488-Jar in mouse skin. Alexa488-Jar accumulated in the wall of
venules (A-green) and capillaries (B), which were stained with CD-31
blood vessel marker (red). The sections were examined with a Confocal
Microscope LSM 510 Meta (Zeiss).
doi:10.1371/journal.pntd.0000727.g005
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www.plosntds.org 7 June 2010 | Volume 4 | Issue 6 | e727Figure 6. Co-localization of Alexa88-labeled toxins with basement membrane. Cryosections were obtained 15 minutes after injection of
10 mg of Alexa488-Jar and 50 mg of Alexa488-BnP1 in mouse skin. Alexa488-Jar showed co-localization with the basement membrane staining with
type IV collagen (red) in the venules and capillaries walls (green). Alexa488-BnP1 did not co-localize with type IV collagen neither in venules nor in
capillaries showing similar pattern observed to Alexa488-BSA (control). The sections were examined with a Confocal Microscope LSM 510 Meta
(Zeiss).
doi:10.1371/journal.pntd.0000727.g006
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vitro, SVMPs bind to extracellular matrix proteins, such as type I
collagen [15,38,39,40], type IV collagen [40], collagen XII and
XIV and the matrilins 1, 3 and 4 [16]. The high affinity for these
extracellular matrix proteins could contribute for the accumula-
tion of the toxin in the damaged tissue, enhancing the catalytic
action of SVMPs towards basement membrane components.
A fine correlation between collagen binding and hemorrhagic
activity has been shown by our group. An anti-SVMP monoclonal
antibody neutralizes hemorrhagic activity and collagen binding of
jararhagin without interfering with its catalytic activity [25].
Recently, it was shown that jararhagin binds with high affinity to
type I collagen and type IV collagen, whereas berythrativase, a
non-hemorrhagic P-III SVMP isolated from B. erythromelas venom,
failed to bind to these substrates [40]. Molecular modeling of the
putative epitopes binding to this monoclonal antibody pinpointed
a motif present in the hemorrhagic toxin jararhagin and absent in
the pro-coagulant enzyme berythractivase, located at the Da-
subdomain of disintegrin-like domain [40]. However, it is
important to consider that a collagen-binding motif was also
detected in the cysteine-rich domain of Atrolysin-A, a hemorrhagic
P-III SVMP [15].
One aspect still unclear is the apparent contradiction between
the results of collagen hydrolysis in vitro and in vivo. In vitro,m o s t
SVMPs (class P-I or P-III) hydrolyse type IV collagen but not
fibrillar collagens [20]. Here, an almost complete disassembly of
hypodermal fibrillar collagen was observed in tissues treated with
jararhagin, but not BnP1. Escalante and co-workers [41] also
observed collagen hydrolysis in vivo. Several fragments of
collagens were detected in the exudates of muscle injected with
BaP1, a class P-I SVMP. Most of the fragments corresponded to
non-fibrillar collagen. However, a fragment corresponding to the
fibrillar collagen V was also identified. According to our results,
class P-I SVMPs induced minor alterations to hypodermal
fibrillar collagen. Thus, it is possible to predict that skin
homogenates of P-III SVMP lesions would contain more
degradation fragments of fibrillar collagens. A possible explana-
tion for the differences observed in vivo could be the disorgani-
zation of fibrils due to the toxin binding allowing the degradation
of fibrillar collagen on hypodermis. However, data explaining
why this occurs only in vivo is still lacking. Other alternative would
be that the injection of SVMPs would induce tissue secretion of
MMPs, able to digest fibrillar collagen. However, this hypothesis
is not consistent with the fast onset of the reaction. Also, P-I
SVMPs are very efficient to induce over-expression of MMPs
[29,42] and they appear to be much less efficient to hydrolyze
collagen in vivo.
Our results confirm previous suppositions that the non-catalytic
domains play a crucial role in the expression of hemorrhagic
activity of P-III SVMPs, implying that non-enzymatic mechanisms
are also involved in bleeding. The hypervariable region of the
cysteine-rich domain is attributed to the binding of SVMPs to a
series of substrates containing von Willebrand factor A domains,
allowing the catalysis of a specific substrate region [16]. Here we
suggest that SVMPs may present additional functional motifs
related to their binding to collagens. The cysteine-rich domain
exosite would be essential for the enzymatic selectivity of the
SVMPs while a disintegrin-like domain collagen binding motif
would be responsible for high affinity binding to collagens and
tissue concentration of the toxin.
The data presented herein are particularly important to
understand the mechanisms involved in the onset of hemorrhage
and could contribute to the rational of alternative treatments for
snakebites victims. Since accumulation of SVMPs at the site of the
bite allows hemorrhage enhancing the local venom effects, the
local administration of metalloproteinases inhibitors could repre-
sent an interesting approach in order to improve the neutralization
of toxins responsible for the local damage. Indeed, it has already
been shown that the local injection of batimastat, a peptidomi-
metic matrix metalloproteinase inhibitor, totally neutralized the
proteolytic, hemorrhagic and dermonecrotic effects induced by
Bothrops asper venom [43]. Moreover, it has recently been shown
that local administration of tetracycline prevented the dermone-
crosis induced by Loxosceles spider venom. In addition to its
antimicrobial properties, tetracycline was also able to inhibit
MMPs, which are important for the progression of dermonecrotic
lesions [44].
In summary, we showed that the strong hemorrhage induced by
class P-III hemorrhagic SVMPs is related to their accumulation at
basement membrane, reaching enzyme concentrations sufficient
for its rapid degradation. This mechanism may serve as a rational
for the design of alternatives in which local administration of
metalloproteinase inhibitors may complement antivenoms in the
neutralization of local tissue damage.
Figure 7. Role of disintegrin-like and cysteine-rich domains on the distribution of jararhagin on skin vasculature. Cryosections were
obtained 15 minutes after injection of 5 mg Alexa488-Jar-C in mouse skin. Alexa488-Jar-C accumulated on venules (A) and capillaries walls (B), and
showed co-localization with basement membrane staining with type IV collagen (C-red). The sections were examined with a Confocal Microscope
LSM 510 Meta (Zeiss).
doi:10.1371/journal.pntd.0000727.g007
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